Topline

TOPLINE

Nasdaq-listed Marex plans more acquisitions, with new Japan office to expand Asia-Pacific presence

Amid geopolitical uncertainty, the firm is being ‘more proactive’ with clients

Vincent Yeo says CDLHT has "a lot of confidence in tourism development in Singapore", with any asset acquisition here "also a land-banking exercise".
TOPLINE

CDLHT eyes rebound after renovation drag as Singapore tourism outlook brightens

Despite stronger magnets elsewhere, Singapore can still play to its strengths in offering safety and global connectivity, says the CEO of the stapled group’s managers

John Stewart, chief executive officer of Digital Core Reit's manager, says Singapore and Japan are potential growth targets.
TOPLINE

Digital Core Reit pivots to ‘offensive’ strategy, targets doubling asset base in 3 years

Its manager looks to capital recycling and sponsor-backed deals to scale

Centurion Corp chief executive Kong Chee Min said the group is taking "baby steps" into the Middle East, where opportunity is ripe.
TOPLINE

Centurion Corp eyes Middle East expansion while shoring up domestic presence

The property player is targeting worker and mid-skilled housing in around three countries in the Middle East

OKP executive director Daniel Or says the group remains "committed to shareholders in delivering sustainable returns".
TOPLINE

OKP poised to benefit from Singapore construction boom, backed by S$136.7 million in cash

With its order book value standing at S$615.9 million, the group expects to remain profitable until end-2027

Jane Sun, CEO of Trip.com Group, says: "As long as people are travelling, we should be okay. The world is a big place."
TOPLINE

Chinese travel giant Trip.com bets on Apac growth as it looks beyond home market

It will strengthen its branding and continue to develop specialised products for the newer audience

Jay Thyagarajan, senior VP for Apac at Novo Nordisk, says that one way the company intends to manage patent expiries is through continued investments in R&D, including work on novel drug formulations.
TOPLINE

‘Treating obesity for the next 100 years’: Ozempic-maker Novo Nordisk targets tripling of Apac patient base

By sales volumes for its GLP-1 drugs, the company’s largest markets in the region are Australia, Japan, South Korea and India

Executive chairman and managing director Choo Chee Onn has not ruled out exiting China, where KSH Holdings has property investments, if the market's economic conditions do not improve.
TOPLINE

Amid global economic uncertainty, KSH Holdings doubles down on Singapore for growth

The construction and property group is eyeing more laboratory construction projects, given its strong track record in the sector

Chua Hsien Yang was appointed the chief executive officer of the manager of Keppel Reit on Jan 1, 2025.
TOPLINE

Keppel Reit eyes diversification into retail with focus on Singapore

Keppel Reit remains anchored in Singapore despite its foray into Australian retail

Alan Tang, Far East Orchard's group CEO, says the Covid-19 pandemic helped the company to firm up its resolve to diversify and strengthen recurring income beyond hotels.
TOPLINE

Beyond hospitality: Far East Orchard leans on student accommodation for recurring income

It aims to expand the segment and build up fund management capabilities